TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Kappa Bioscience AS
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Turnover |
308,808
|
237,967
|
282,766 |
Financial expenses |
23,517
|
45,062
|
15,870 |
Earnings before taxes |
71,151
|
70,717
|
82,783 |
Total assets |
497,911
|
367,374
|
276,388 |
Current assets |
227,038
|
263,611
|
185,803 |
Current liabilities |
153,980
|
93,525
|
85,937 |
Equity capital |
268,611
|
236,048
|
182,382 |
- share capital |
1,608
|
1,560
|
1,452 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Solvency |
53.9%
|
64.3%
|
66.0% |
Turnover per employee | |||
Profit as a percentage of turnover |
23.0%
|
29.7%
|
29.3% |
Return on assets (ROA) |
19.0%
|
31.5%
|
35.7% |
Current ratio |
147.4%
|
281.9%
|
216.2% |
Return on equity (ROE) |
26.5%
|
30.0%
|
45.4% |
Change turnover |
63,467
|
-65,785
|
89,002 |
Change turnover % | 26% | 46% | |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.